The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Shah, Suresh Chandra
    Company Director born in January 1952
    Individual (2 offsprings)
    Officer
    2007-10-31 ~ now
    OF - director → CIF 0
    Mr Suresh Chandra Shah
    Born in January 1952
    Individual (2 offsprings)
    Person with significant control
    2016-10-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Gudka, Nilesh Kumar
    Pharmacist born in February 1957
    Individual (2 offsprings)
    Officer
    2007-10-31 ~ now
    OF - director → CIF 0
    Gudka, Nilesh Kumar
    Individual (2 offsprings)
    Officer
    2007-10-31 ~ now
    OF - secretary → CIF 0
parent relation
Company in focus

AVENUE PHARM INVESTMENTS LTD

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Property, Plant & Equipment
269,291 GBP2023-12-31
277,070 GBP2022-12-31
Cash at bank and in hand
19,047 GBP2023-12-31
16,165 GBP2022-12-31
Net Current Assets/Liabilities
6,487 GBP2023-12-31
4,110 GBP2022-12-31
Total Assets Less Current Liabilities
275,778 GBP2023-12-31
281,180 GBP2022-12-31
Creditors
Amounts falling due after one year
-183,758 GBP2023-12-31
-203,757 GBP2022-12-31
Net Assets/Liabilities
92,020 GBP2023-12-31
77,423 GBP2022-12-31
Equity
Called up share capital
1,000 GBP2023-12-31
1,000 GBP2022-12-31
Retained earnings (accumulated losses)
91,020 GBP2023-12-31
76,423 GBP2022-12-31
Equity
92,020 GBP2023-12-31
77,423 GBP2022-12-31
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Land and buildings
388,969 GBP2023-12-31
388,969 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings
119,678 GBP2023-12-31
111,899 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings
7,779 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Land and buildings
269,291 GBP2023-12-31
277,070 GBP2022-12-31
Taxation/Social Security Payable
Amounts falling due within one year
11,760 GBP2023-12-31
11,255 GBP2022-12-31
Other Creditors
Amounts falling due within one year
800 GBP2023-12-31
800 GBP2022-12-31
Amounts falling due after one year
183,758 GBP2023-12-31
203,757 GBP2022-12-31

  • AVENUE PHARM INVESTMENTS LTD
    Info
    Registered number 06413475
    37 Donnington Road, Kenton, Harrow HA3 0NB
    Private Limited Company incorporated on 2007-10-31 (17 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.